Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Imidex
Denver, Colorado, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
VisiRad XR, Imidex’s lead product, demonstrated 83% sensitivity in detecting lung nodules and masses as small as 6mm on chest X-rays. It was validated in multi-center and stand-alone clinical studies, enabling early detection of lung cancer in broader populations and facilitating downstream patient management. The platform was commercially cleared by the FDA and used in real-world settings before being sold along with its dataset and IP in April 2025.
- Therapeutic areas
- OncologyPulmonology
- Modalities
- DeviceArtificial intelligence (AI)-powered diagnostic platform
- Industry
- Medical Imaging
02
Partnerships
Orbit Genomics (strategic collaboration for combined AI imaging and DNA-based liquid biopsy early lung cancer detection)Spesana (partnership for measuring AI’s impact in downstream lung nodule/mass detection and identifying at-risk patients)
Beyond the preview
Go deeper on Imidex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Imidex.